Global Non-Hormonal Contraception Market

Non-Hormonal Contraception Market Size, Share, Growth Analysis, By Gender(Male and Female), By Product type(Condoms, Diaphragms, Cervical Caps, Spermicides), By Distribution channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2065 | Region: Global | Published Date: July, 2024
Pages: 157 | Tables: 91 | Figures: 76

Non-Hormonal Contraception Market Competitive Landscape

Non-hormonal contraceptives are an effective way to prevent pregnancy without relying on hormones. Some popular options include barrier methods like condoms and diaphragms, as well as intrauterine devices (IUDs) and natural family planning methods. While condoms are widely available and offer protection against sexually transmitted infections, diaphragms require a prescription and must be used with a spermicide. IUDs are a long-term option that can last up to 10 years, but they also require a medical professional for insertion. Natural family planning methods involve tracking ovulation and abstaining from sex during the fertile window. Overall, the competitive landscape for non-hormonal contraceptives offers a variety of options for individuals seeking safe and effective birth control.

Non-Hormonal Contraception Market Top Player’s Company Profiles

  • Bayer AG
  • Merck & Co., Inc.
  • Allergan
  • Cooper Surgical Inc.
  • Mayer Laboratories, Inc.
  • The Female Health Company
  • Agile Therapeutics
  • Afaxys, Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Church & Dwight Co., Inc.
  • The Population Council, Inc.
  • Ansell Ltd.
  • Medicines360
  • Mylan N.V.
  • Okamoto Industries Inc.
  • Reckitt Benckiser Group plc
  • V-Care Pharma Pvt. Ltd.
  • Fuji Latex Co., Ltd.
  • Veru Inc.

Non-Hormonal Contraception Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Non-Hormonal Contraception Market size was valued at USD 28.86 billion in 2022 and is poised to grow from USD 30.74 billion in 2023 to USD 50.87 billion by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

Non-hormonal contraceptives are an effective way to prevent pregnancy without relying on hormones. Some popular options include barrier methods like condoms and diaphragms, as well as intrauterine devices (IUDs) and natural family planning methods. While condoms are widely available and offer protection against sexually transmitted infections, diaphragms require a prescription and must be used with a spermicide. IUDs are a long-term option that can last up to 10 years, but they also require a medical professional for insertion. Natural family planning methods involve tracking ovulation and abstaining from sex during the fertile window. Overall, the competitive landscape for non-hormonal contraceptives offers a variety of options for individuals seeking safe and effective birth control. 'Bayer AG', 'Merck & Co., Inc.', 'Allergan', 'Cooper Surgical Inc.', 'Mayer Laboratories, Inc.', 'The Female Health Company', 'Agile Therapeutics', 'Afaxys, Inc.', 'Pfizer Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Church & Dwight Co., Inc.', 'The Population Council, Inc.', 'Ansell Ltd.', 'Medicines360', 'Mylan N.V.', 'Okamoto Industries Inc.', 'Reckitt Benckiser Group plc', 'V-Care Pharma Pvt. Ltd.', 'Fuji Latex Co., Ltd.', 'Veru Inc.'

The increasing awareness about contraception is a major driver of the global non-hormonal contraception market. With the growing trend of family planning and the need for effective and safe contraceptive methods, consumers are seeking out non-hormonal options. The availability of educational resources and counseling services has also contributed to the increasing awareness levels among consumers, as they become better informed about the different types of contraceptive methods available to them. This has led to a higher demand for non-hormonal contraceptives in the market, as consumers seek out products that are safe, effective, and suited to their individual needs. As a result, manufacturers are developing new and innovative non-hormonal contraceptive products to meet the growing demand.

One key market trend in the global non-hormonal contraception market is the increasing demand for natural and organic contraceptive products. Consumers are becoming more aware of the potential side effects associated with hormonal contraception and are seeking alternatives that are free from synthetic hormones and chemicals. Natural and organic non-hormonal contraceptives, such as condoms and natural family planning methods, are gaining popularity as they are perceived to be safer and more eco-friendly. The trend towards natural and organic products is also being driven by the growing focus on sustainability and environmental consciousness.

North America dominates the global non-hormonal contraception market, owing to the high awareness levels, favorable reimbursement policies, and the availability of advanced healthcare infrastructure in the region. The United States is the largest market in North America, due to the high demand for non-hormonal contraceptive products and the presence of major players in the region. In addition, the growing trend of delaying childbirth and the increasing preference for non-invasive and reversible contraceptive methods among women are expected to drive the market growth in North America. The rising incidences of sexually transmitted infections and the need for effective prevention methods are also contributing to the growth of the non-hormonal contraception market in the region. Furthermore, the increasing adoption of technological advancements in the development of non-hormonal contraceptive products is expected to create opportunities for market growth in the region. The availability of various non-hormonal contraceptive products such as condoms, cervical caps, and diaphragms in retail pharmacies and online channels is expected to further drive the market growth in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Hormonal Contraceptive Market
Buy Now GET FREE SAMPLE
Contraceptives Market
Buy Now GET FREE SAMPLE
Contraceptive Drugs Market
Buy Now GET FREE SAMPLE
U.S. Contraceptive Market
Buy Now GET FREE SAMPLE
Contraceptive Devices Market
Buy Now GET FREE SAMPLE
Infertility Treatment Market
Buy Now GET FREE SAMPLE
Fertility Supplements Market
Buy Now GET FREE SAMPLE
Prenatal Vitamin Supplement Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Non-Hormonal Contraception Market

Report ID: SQMIG35D2065

$5,300
BUY NOW GET FREE SAMPLE